These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12366664)

  • 1. The relevance of oncogenes as prognostic markers in cervical cancer.
    Soh LT; Heng D; Lee IW; Ho TH; Hui KM
    Int J Gynecol Cancer; 2002; 12(5):465-74. PubMed ID: 12366664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas.
    Iwasaka T; Yokoyama M; Oh-uchida M; Matsuo N; Hara K; Fukuyama K; Hachisuga T; Fukuda K; Sugimori H
    Gynecol Oncol; 1992 Sep; 46(3):298-303. PubMed ID: 1326470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection.
    Zhang A; Månér S; Betz R; Angström T; Stendahl U; Bergman F; Zetterberg A; Wallin KL
    Int J Cancer; 2002 Oct; 101(5):427-33. PubMed ID: 12216070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
    Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
    Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
    Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
    Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papilloma virus types in preinvasive cervical lesions.
    Mourón SA; Abba MC; Güerci A; Gómez MA; Dulout FN; Golijow CD
    Mutat Res; 2000 Aug; 469(1):127-34. PubMed ID: 10946249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
    Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
    BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations and amplification of oncogenes in endometrial cancer.
    Niederacher D; An HX; Cho YJ; Hantschmann P; Bender HG; Beckmann MW
    Oncology; 1999; 56(1):59-65. PubMed ID: 9885379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of ras point mutations and human papillomavirus 16 and 18 in cervical carcinomata and their metastases.
    Willis G; Jennings B; Ball RY; New NE; Gibson I
    Gynecol Oncol; 1993 Jun; 49(3):359-64. PubMed ID: 8390962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-RAS point mutation, and amplification of C-MYC and C-ERBB2 in colon adenocarcinoma.
    Kruszewski W; Kowara R; Rzepko R; Warezak C; Zieliński J; Gryglewski G; Kopacz A; Jastrzebski T; Pawełczyk T
    Folia Histochem Cytobiol; 2004; 42(3):173-9. PubMed ID: 15493579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions.
    Pelisson I; Soler C; Pechoux C; Chignol MC; Viac J; Euvrard S; Chardonnet Y
    J Dermatol Sci; 1992 Jan; 3(1):56-67. PubMed ID: 1317208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive detection of c-myc p64, c-myc p67 and c-erbb-2 in colorectal cancer.
    Lagerholm S; Lagerholm S; Dutta S; Nair P
    Scand J Gastroenterol; 2005 Nov; 40(11):1343-50. PubMed ID: 16334444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV-16 E2 physical status and molecular evolution in vivo in cervical carcinomas.
    Kahla S; Kochbati L; Chanoufi MB; Maalej M; Oueslati R
    Int J Biol Markers; 2014 Mar; 29(1):e78-85. PubMed ID: 24170557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
    Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
    Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
    Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
    Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the P16 gene in uterine cervical carcinoma from Indian patients.
    Tripathi A; Banerjee S; Roy A; Roychowdhury S; Panda CK
    Int J Gynecol Cancer; 2003; 13(4):472-9. PubMed ID: 12911724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.